F

FutureChem Co Ltd
KOSDAQ:220100

Watchlist Manager
FutureChem Co Ltd
KOSDAQ:220100
Watchlist
Price: 16 190 KRW 2.6% Market Closed
Market Cap: 357.8B KRW
Have any thoughts about
FutureChem Co Ltd?
Write Note

FutureChem Co Ltd
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

FutureChem Co Ltd
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
F
FutureChem Co Ltd
KOSDAQ:220100
Note Receivable
â‚©2.2B
CAGR 3-Years
63%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Note Receivable
â‚©309.3B
CAGR 3-Years
16%
CAGR 5-Years
26%
CAGR 10-Years
N/A
K
Knotus Co Ltd
KOSDAQ:278650
Note Receivable
â‚©970m
CAGR 3-Years
6%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
S
ST Pharm Co Ltd
KOSDAQ:237690
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Note Receivable
â‚©98.1m
CAGR 3-Years
N/A
CAGR 5-Years
0%
CAGR 10-Years
N/A
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Note Receivable
â‚©1.5k
CAGR 3-Years
-98%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

FutureChem Co Ltd
Glance View

Market Cap
357.7B KRW
Industry
Life Sciences Tools & Services

FutureChem Co., Ltd. engages in the manufacture of medical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2015-08-13. Co.,Ltd is a Korea-based company principally engaged in the manufacture and distribution of radiopharmaceuticals. The firm manufactures radiopharmaceuticals including radiopharmaceuticals for diagnosis of various cancers such as lung cancer and for the early diagnosis of Parkinson's disease and Alzheimer's disease. The firm also produces medical automation modules such as cubes and disposable goods including disposable cassettes, reagent kits, radio-caps and kryptofix kits; productions of photon emission tomography (PET) and single photon emission computed tomography (SPECT) precursors for radiopharmaceuticals and other chemicals such as metal chelating agents, fluorescence probes, peptides.

Intrinsic Value
1 218.19 KRW
Overvaluation 92%
Intrinsic Value
Price
F

See Also

What is FutureChem Co Ltd's Note Receivable?
Note Receivable
2.2B KRW

Based on the financial report for Sep 30, 2024, FutureChem Co Ltd's Note Receivable amounts to 2.2B KRW.

What is FutureChem Co Ltd's Note Receivable growth rate?
Note Receivable CAGR 5Y
45%

Over the last year, the Note Receivable growth was -22%. The average annual Note Receivable growth rates for FutureChem Co Ltd have been 63% over the past three years , 45% over the past five years .

Back to Top